A Study of MabThera (Rituximab) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia.

Clinical trial NCT00738374 · COMPLETED

Trial details

NCT number: NCT00738374
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphocytic Leukemia, Chronic

Start date: 2008-11-03
Primary completion: 2013-01-14
Enrollment: 97

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.